Delivery Order SPE2DB22D3501-SPE2DB23FXC53
Award Date 9/5/23
Potential Completion Date 9/26/23
Potential Value $127K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $56,490.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 28 capsules of the pharmaceutical Revlimid 10 mg. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order period of performance is from August 18, 2023 through September 11, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order supports DLA's mission to provide critical...
- The Defense Logistics Agency awarded a $157,346 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 100 capsules of the pharmaceutical Revlimid 5 mg. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one month period concluding in mid-October 2023. No...
- The Defense Logistics Agency awarded a $14,122.63 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 28 capsules of the pharmaceutical Revlimid 10 mg. The order is being fulfilled under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will deliver the Revlimid capsules to a facility in Conshohocken, Pennsylvania by September 12, 2023 to support DLA and DoD medical readiness...
- The Defense Logistics Agency awarded a $51,089.97 delivery order to AmerisourceBergen Drug Corp for Revlimid 10 mg capsules (28-count) on September 9, 2025, with performance completion targeted for September 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately ninety-five thousand dollars to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide one hundred capsules of the pharmaceutical Revlimid to support the Defense Logistics Agency's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three week period concluding in early August. As the prime contractor,...
- The Defense Logistics Agency awarded a $25,840.56 delivery order to AmerisourceBergen Drug Corp for 28-count units of Revlimid 10 mg capsules under a firm fixed price contract. The award was made on July 14, 2025, with an ultimate completion date of August 4, 2025. AmerisourceBergen will perform the contract at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive award with no set-aside designation, reflecting the contractor's capability to...
- The Defense Logistics Agency awarded a $12,329.16 delivery order to AmerisourceBergen Drug Corp for 28 capsules of Revlimid 5 mg on July 28, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order valued at approximately $51.7K to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count units). This firm fixed-price delivery order, awarded on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a non-competitive procurement executed under an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $12,993.03 to AmerisourceBergen Drug Corp for the supply of Revlimid 5 mg capsules (quantity: 28 units). This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of December 12, 2025. The pharmaceutical supply will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $373,171.40 to Amerisourcebergen Drug Corporation for the provision of 4562106624 REVLIMID 10 MG CAPSULE 100S. The firm fixed price order calls for the delivery of pharmaceutical products to a facility located in Conshohocken, Pennsylvania by September 29, 2023 in support of Department of Defense requirements. Amerisourcebergen will serve as the prime contractor on the order placed under an unspecified multiple award contract...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB23FXC53Delivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred twenty-seven thousand four hundred forty-two dollars and forty-six cents ($127,442.46) to Amerisourcebergen Drug Corporation for the provision of twenty-eight (28) capsules of the pharmaceutical Revlimid (lenalidomide) per package. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period spanning September 5 through September 26, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order supports the Agency's stocking and distribution of prescription drugs for military treatment facilities nationwide.
Generated 12/20/23, 3:03 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $127.4k | 9/5/23 |